Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat

被引:77
|
作者
Geier, A
Dietrich, CG
Gerloff, T
Haendly, J
Kullak-Ublick, GA
Stieger, B
Meier, PJ
Matern, S
Gartung, C
机构
[1] Rhein Westfal TH Aachen, Dept Internal Med 3, D-52074 Aachen, Germany
[2] Charite Humboldt Univ, Dept Clin Pharmacol, Berlin, Germany
[3] Univ Zurich Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland
[4] Univ Zurich Hosp, Dept Internal Med, Div Clin Pharmacol, CH-8091 Zurich, Switzerland
[5] Univ Zurich Hosp, Dept Internal Med, Div Toxicol, CH-8091 Zurich, Switzerland
来源
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES | 2003年 / 1609卷 / 01期
关键词
organic anion transporter; estrogen; cholestasis;
D O I
10.1016/S0005-2736(02)00657-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background/Aims: Estrogen-mediated cholestasis is an important clinical entity, but its molecular pathophysiology is still not fully understood. Impaired sodium-dependent uptake of bile acids has been associated with diminished expression of a basolateral Na+/bile acid cotransporter (Ntcp), whereas sodium-independent uptake is maintained despite a down-regulation of the organic anion transporter Oatpl. Thus, expression of the two other rat Oatps (Oatps2 and -4) was determined in estrogen-induced cholestasis. In addition, known transactivators of Oatp2 and Ntcp were studied to further characterize transcriptional regulation of these transporter genes. Methods: Hepatic protein and mRNA expression of various Oatps (1, 2, 4) in comparison to Ntcp were analyzed after 0.5, 1, 3 and 5 days of ethinylestradiol (EE) treatment (5 mg/kg) in rats. Binding activities of Oatp2 and Ntcp transactivators were assessed by electrophoretic mobility shift assays. Results: All basolateral. Oatps (1, 2 and 4) were specifically down-regulated at the protein level by 30-40% of controls, but less pronounced than Ntcp (minus 70-80%). In contrast to unaltered Oatp4 mRNA levels, Oatp I and Oatp2 mRNAs were reduced to various extents (minus 40-90% of controls). Binding activity of known transactivators of Ntcp and Oatp2 such as hepatocyte nuclear factor I (HNF1), CAAT enhancer binding protein alpha (C/EBPalpha) and pregnane X receptor (PXR) were also diminished during the time of cholestasis. Conclusions: Estrogen-induced cholestasis results in a down-regulation of all basolateral organic anion transporters. The moderate decline in expression of Oatp 1, -2 and -4 may explain the unchanged sodium-independent transport of bile acids due to overlapping substrate specificity. Reduction in transporter gene expression seems to be mediated by a diminished nuclear binding activity of transactivators such as HNF1, C/EBP and PXR by estrogens. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:87 / 94
页数:8
相关论文
共 31 条
  • [1] Protective impact of lycopene on ethinylestradiol-induced cholestasis in rats
    Wadie, Walaa
    Mohamed, Aya Hamada
    Masoud, Marwa Ashour
    Rizk, Hanan Amin
    Sayed, Helmy Moawad
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (03) : 447 - 455
  • [2] Protective impact of lycopene on ethinylestradiol-induced cholestasis in rats
    Walaa Wadie
    Aya Hamada Mohamed
    Marwa Ashour Masoud
    Hanan Amin Rizk
    Helmy Moawad Sayed
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2021, 394 : 447 - 455
  • [3] Metformin impairs bile acid homeostasis in ethinylestradiol-induced cholestasis in mice
    Faradonbeh, Fatemeh Alaei
    Sa, Ivone Igreja
    Lastuvkova, Hana
    Cermanova, Jolana
    Hroch, Milos
    Faistova, Hana
    Mokry, Jaroslav
    Nova, Zuzana
    Uher, Martin
    Nachtigal, Petr
    Pavek, Petr
    Micuda, Stanislav
    CHEMICO-BIOLOGICAL INTERACTIONS, 2021, 345
  • [4] Role of AMP-activated protein kinase α1 in 17α-ethinylestradiol-induced cholestasis in rats
    Li, Xiaojiaoyang
    Liu, Runping
    Luo, Lan
    Yu, Linxi
    Chen, Xin
    Sun, Lixin
    Wang, Tao
    Hylemon, Phillip B.
    Zhou, Huiping
    Jiang, Zhenzhou
    Zhang, Luyong
    ARCHIVES OF TOXICOLOGY, 2017, 91 (01) : 481 - 494
  • [5] Role of AMP-activated protein kinase α1 in 17α-ethinylestradiol-induced cholestasis in rats
    Xiaojiaoyang Li
    Runping Liu
    Lan Luo
    Linxi Yu
    Xin Chen
    Lixin Sun
    Tao Wang
    Phillip B. Hylemon
    Huiping Zhou
    Zhenzhou Jiang
    Luyong Zhang
    Archives of Toxicology, 2017, 91 : 481 - 494
  • [6] Labetalol and soluble endoglin aggravate bile acid retention in mice with ethinylestradiol-induced cholestasis
    Sa, Ivone Cristina Igreja
    Tripska, Katarina
    Faradonbeh, Fatemeh Alaei
    Hroch, Milos
    Lastuvkova, Hana
    Schreiberova, Jolana
    Kacerovsky, Marian
    Pericacho, Miguel
    Nachtigal, Petr
    Micuda, Stanislav
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [7] Torsemide renal clearance and genetic variation in luminal and basolateral organic anion transporters
    Vormfelde, Stefan V.
    Schirmer, Markus
    Hagos, Yohannes
    Toliat, Mohammad R.
    Engelhardt, Sabine
    Meineke, Ingolf
    Burckhardt, Gerhard
    Nuernberg, Peter
    Brockmoeller, Juergen
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (03) : 323 - 335
  • [8] Hydrogen peroxide downregulates human organic anion transporters in the basolateral membrane of the proximal tubule
    Takeda, M
    Hosoyamada, M
    Cha, SH
    Sekine, T
    Endou, H
    LIFE SCIENCES, 2000, 68 (06) : 679 - 687
  • [9] Paeoniflorin alleviates 17α-ethinylestradiol-induced cholestasis via the farnesoid X receptor-mediated bile acid homeostasis signaling pathway in rats
    Wang, Rulin
    Yuan, Tengteng
    Sun, Jing
    Yang, Menghuan
    Chen, Yunna
    Wang, Lei
    Wang, Yanyan
    Chen, Weidong
    Peng, Daiyin
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [10] Regulation of hepatobiliary transporters during cholestasis may mediate the phenomenon of adaptation to cholestasis induced by rifampicin in rats
    Ren, Xiaofei
    Wang, Wei
    Cai, Yi
    Xu, Jianming
    Cao, Liyu
    Hu, Wen
    Chen, Xi
    Song, Yulin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (04): : 4473 - 4481